These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25611008)

  • 1. Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda.
    Nalwoga A; Cose S; Wakeham K; Miley W; Ndibazza J; Drakeley C; Elliott A; Whitby D; Newton R
    Trop Med Int Health; 2015 May; 20(5):665-672. PubMed ID: 25611008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands.
    Nalwoga A; Webb EL; Chihota B; Miley W; Walusimbi B; Nassuuna J; Sanya RE; Nkurunungi G; Labo N; Elliott AM; Cose S; Whitby D; Newton R
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007776. PubMed ID: 31618208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa.
    Malope-Kgokong BI; Macphail P; Mbisa G; Ratshikhopha E; Maskew M; Stein L; Sitas F; Whitby D
    Infect Agent Cancer; 2010 Aug; 5():14. PubMed ID: 20807396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
    Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
    Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.
    Wakeham K; Johnston WT; Nalwoga A; Webb EL; Mayanja BN; Miley W; Elliott AM; Whitby D; Newton R
    Int J Cancer; 2015 Jun; 136(12):2822-30. PubMed ID: 25395177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental determinants of Kaposi's sarcoma-associated herpesvirus (KSHV) transmission in rural Uganda (ENDKU study): Contributions to research on KSHV infection and reactivation in African children; A longitudinal cohort study.
    Sabourin KR; Nalwoga A; Whitby D; Newton R; Rochford R
    Cancer Epidemiol; 2022 Jun; 78():102154. PubMed ID: 35381467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute
    Oluoch PO; Forconi CS; Oduor CI; Ritacco DA; Akala HM; Bailey JA; Juliano JJ; Ong'echa JM; Münz C; Moormann AM
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
    Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
    Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992-2008.
    Sabourin KR; Mugisha J; Asiki G; Nalwoga A; Labo N; Miley W; Beyer R; Rochford R; Johnston TW; Newton R; Whitby D
    Infect Agent Cancer; 2023 Sep; 18(1):55. PubMed ID: 37775773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum Malaria Is Associated With Increased Kaposi Sarcoma-Associated Herpesvirus (KSHV) Seropositivity and Higher KSHV Antibody Breadth and Magnitude: Results of a Case-Control Study From Rural Uganda.
    Nalwoga A; Sabourin KR; Miley W; Jackson C; Maktabi M; Labo N; Mugisha J; Whitby D; Rochford R; Newton R
    J Infect Dis; 2024 Feb; 229(2):432-442. PubMed ID: 37536670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
    Ziegler JL; Katongole-Mbidde E
    Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs.
    Sabourin KR; Ogolla S; Daud II; Jackson CL; Miley W; Labo N; Whitby D; Rochford R
    Infect Agent Cancer; 2020 Nov; 15(1):71. PubMed ID: 33292357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.
    Stolka K; Ndom P; Hemingway-Foday J; Iriondo-Perez J; Miley W; Labo N; Stella J; Abassora M; Woelk G; Ryder R; Whitby D; Smith JS
    Cancer Epidemiol; 2014 Apr; 38(2):137-43. PubMed ID: 24631417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C
    Br J Cancer; 2003 Aug; 89(3):502-4. PubMed ID: 12888820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):226-32. PubMed ID: 12455037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda.
    Wakeham K; Webb EL; Sebina I; Nalwoga A; Muhangi L; Miley W; Johnston WT; Ndibazza J; Whitby D; Newton R; Elliott AM
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):228-33. PubMed ID: 23403859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.